Could cause temporary or reversible harm; serious harm is unlikely.
Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a customer complaint trend regarding capsule breakage.
| Distributed by / for | Teva Pharmaceuticals USA, Sellersville, PA 18960 |
| NDC | 0093-7542-06 |
| Full product label | Duloxetine Delayed-Release Capsules, USP, 20 mg, Rx Only, 60 capsules per Bottle, Manufactured in Israel by: Teva Pharmaceutical IND, LTD, Jerusalem, Israel, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-7542-06 |
| Recalling firm | Teva Pharmaceuticals USA |
| Distribution | Nationwide, Guam, Puerto Rico, American Samoa, Virgin Islands. |
| Quantity | 127,585 Bottles |
| Recall initiated | 2014-03-04 |
| Report date | 2014-04-09 |
| Recall completed | 2014-11-12 |
| Recall number | D-1182-2014 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Horsham PA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗